Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.
C. Morillo +20 more
semanticscholar +3 more sources
FUNDAMENTO: Pouco se sabe sobre o desfecho dos pacientes com cardiopatia chagásica, em comparação aos pacientes com miocardiopatia dilatada idiopática na era contemporânea. OBJETIVO: Comparar o desfecho dos pacientes chagásicos com insuficiência cardíaca
Amanda Pires Barbosa +4 more
doaj
CHARITY: Cha gas car diomyopathy bi soprolol int ervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973] [PDF]
Franklin R Quiros +4 more
openalex +1 more source
REACTIVATION OF CHAGAS DISEASE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT: CASE SERIES
Chagas disease, caused by Trypanosoma cruzi, remains an important public health problem in the Americas. Although the most prevalent chronic form is cardiac, central nervous system reactivation is rare but severe, particularly in immunosuppressed ...
Clara dos Reis Aguiar +4 more
doaj +1 more source
Chagas Cardiomyopathy Presenting as Symptomatic Bradycardia: An Underappreciated Emerging Public Health Problem in the United States [PDF]
Richard Jesse Durrance +4 more
openalex +1 more source
Post Hoc Analyses of SHIFT and PARADIGM-HF Highlight the Importance of Chronic Chagas' Cardiomyopathy Comment on: “Safety Profile and Efficacy of Ivabradine in Heart Failure Due to Chagas Heart Disease: A Post Hoc Analysis of the SHIFT Trial” by Bocchi et al. [PDF]
Félix José Alvarez Ramires +10 more
openalex +1 more source
Chagas disease (CD) is a major cause of cardiomyopathy in Latin America, and migration movements have now spread the disease worldwide. However, data regarding Chagas cardiomyopathy (CC) and the usefulness of echocardiography in non endemic countries are still scarce. We selected 485 patients in the chronic phase of CD from two Spanish settings.
Sánchez-Montalvá, Adrián|| +8 more
openaire +1 more source

